HFCL Limited has successfully concluded its Qualified Institutions Placement (QIP) which opened on December 22, 2025. The company has approved the allocation of 8,79,29,651 equity shares to eligible institutional buyers. The shares were issued at a price of ₹62.55 per share, representing a 5% discount to the floor price of ₹65.84. This significant capital raise will likely be utilized to fund expansion plans and strengthen the company's financial position in the telecom infrastructure space.

HFCL Limited has officially launched its Qualified Institutions Placement (QIP) on December 22, 2025, to raise capital from institutional investors. The floor price for the issue has been fixed at ₹65.84 per equity share, based on SEBI pricing formulas. The company retains the discretion to offer a discount of up to 5% on this floor price to participating investors. This fundraise follows a series of approvals from the Board in July 2025 and shareholders in September 2025.

HFCL Limited's Fund Raising Committee has formally approved the issuance of equity shares through a Qualified Institutions Placement (QIP) on December 22, 2025. This decision follows earlier approvals from the Board of Directors in July 2025 and shareholders in September 2025. The shares will have a face value of ₹1 each, aimed at raising capital under SEBI ICDR Regulations. This move indicates the company is moving forward with its capital expansion plans to support its business operations and growth initiatives.

HFCL Limited has officially approved the issuance of equity shares through a Qualified Institutions Placement (QIP) following a committee meeting on December 22, 2025. This move follows prior board approval from July 2025 and shareholder approval obtained during the Annual General Meeting in September 2025. The issuance will involve equity shares with a face value of ₹1 each. While the specific fundraise amount was not disclosed in this filing, the activation of the QIP mechanism indicates an imminent capital infusion to support the company's growth or capital structure.

Fineotex Chemical Limited (FCL) has acquired a 53.33% controlling stake in the US-based CrudeChem Technologies (CCT) group for approximately $11.5 million. The acquired entities report a combined annual revenue of $68 million, making the deal highly EPS-accretive with a low price-to-sales ratio of approximately 0.3x. This strategic move targets the $11.5 billion North American oilfield chemicals market and aligns with FCL's goal to build a $200 million oilfield specialty chemicals business. Financial consolidation is expected to begin effectively from January 1, 2026.

Fineotex Chemical Limited (FCL) has entered into a definitive agreement to acquire a 53.33% controlling stake in the US-based CrudeChem Technologies group for approximately $11.5 million. The acquired entities report a combined annual revenue of $68 million, indicating a highly attractive acquisition valuation of approximately 0.3x price-to-sales. This strategic move provides FCL with immediate access to the $11.5 billion North American oilfield chemicals market and Tier 1 global energy producers. The acquisition is expected to be immediately EPS-accretive and supports FCL's long-term goal of building a $200 million oilfield chemicals business.

HDFC Life's Capital Raising Committee has approved the issuance of unsecured, subordinated Non-convertible Debentures (NCDs) for an aggregate amount of up to ₹750 crore. The fundraise consists of a base issue of ₹700 crore and a green shoe option of ₹50 crore. These instruments have a face value of ₹1 lakh each and a tenure of 10 years. This move is intended to strengthen the company's capital base and support its solvency margins for future growth.

Fineotex Chemical Limited, through its subsidiary Fineotex Biotex Healthguard FZE, has acquired equity interests in FrackMex Equipment, CrudeChem Technology, Oil Pro Advantage, and Lonestar Technoboost. The acquisition aims to expand Fineotex's business in the Specialty Chemical Sector. CrudeChem Technology's turnover for FY 2024-25 was USD 5,30,21,551. Fineotex Biotex Healthguard FZE acquires 53.33% stake in each of the entities. The cost of acquisition for CrudeChem Technology is upto USD 1,10,07,360.

Fineotex Chemical Limited (FCL) has announced a strategic acquisition of a leading U.S. Specialty Oilfield Chemicals Group through its wholly-owned subsidiary, Fineotex Biotex Healthguard FZE. The acquisition includes equity interests in FrackMex Equipment, CrudeChem Technology, Oil Pro Advantage INC, and Lonestar Technoboost LLC. CrudeChem Technology LLC's turnover was USD 53,021,551 in FY 2024-25. The company aims to build a $200 million oil field chemical business in the coming years.

Fineotex Chemical Limited (FCL) has announced a strategic acquisition of CrudeChem Technologies Group, a US-based specialty chemical manufacturer, through its subsidiary. This acquisition aims to build a $200 million oil field chemical business. The North American market represents an $11.5 billion opportunity in 2025. FCL plans to increase its investment and ownership in the coming years, holding a controlling stake initially.

Fineotex Chemical Limited (FCL) successfully exercised warrants on a preferential basis on November 21, 2025. The promoter group meaningfully participated in the exercise, demonstrating strong confidence in the company's strategic direction. The funds raised will be used for working capital requirements and potential acquisitions to support expansion plans. This move is expected to strengthen FCL's position in both domestic and international markets. Investors should note this as a positive sign of internal confidence.